Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the ...
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and ...
How to get tickets and presale for Joan Jett and the Blackhearts’ Glasgow show this summer. Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website ...
Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...
CraftyCrafty.tv today announced the continued expansion of its Tutorials section. SC, UNITED STATES, January 13, 2026 /EINPresswire.com/ — CraftyCrafty.tv today ...
The MarketWatch News Department was not involved in the creation of this content. -- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is ...
Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is a novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). The ...
Just under two months since Wolf Alice wrapped up a triumphant duo of headline shows at London’s O2 Arena, the band have announced another gig for the capital. And not only is this one huge – it’s set ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results